宫癌中的植物化学物质:表观遗传概述
Noha Elzeiny1, Ayman El Sayed Shafei2, Sherin Wagih2
1Departement of Medical Biochemistry & Molecular Biology, Faculty of Medicine Ain Shams University, Cairo, 11566, Egypt.
Epigenomics
|November 2, 2023
概括
植物化学物质通过向表观遗传改变,在宫癌治疗中表现有前途. 对这些天然化合物的进一步研究可能会导致对这种常见的女性恶性瘤的更安全,更有效的治疗方法.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 宫癌是全球女性的主要恶性瘤,通常是由HPV感染引起的.
- 遗传和表观遗传变化驱动子宫癌的发展.
- 目前的治疗方法具有显著的不良影响,突出显示了对新型治疗方法的需求.
研究的目的:
- 审查植物化学品在宫癌中的表观遗传影响.
- 探索植物化学物质作为潜在的预防和治疗剂.
- 了解植物化学物质在宫癌相关的表观遗传修饰中的作用.
主要方法:
- 对植物化学物质和宫癌研究的文献综述.
- 对由植物化学物质准的表观遗传机制的分析.
- 综合了关于植物化学药物的有效性和安全性的研究结果.
主要成果:
- 植物化学物质在调节宫癌的表观遗传变化方面具有潜力.
- 通过表观遗传路径,各种天然化合物表现出抗癌特性.
- 有证据表明,植物化学物质可以单独使用或结合治疗.
结论:
- 植物化学物质为开发更安全的宫癌治疗提供了一个有希望的途径.
- 用植物化学品向表观遗传机制是未来研究的关键领域.
- 对植物化学物质的进一步研究可能会导致宫癌的更好的预防和治疗策略.
相关概念视频
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
Positive Regulator Molecules
5.5K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.5K


